Maximizing treatment benefits and unlocking the potential of proactive extended dosing for patients with retinal disease
Advertisement
Advertisement
Trending on Modern Retina
1
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
2
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
3
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
4
Ophthalmic drug shortages more frequent, longer lasting than average
5